Excillum and Bruker AXS Collaborates to Develop X-ray Diffraction Solutions based on Bright X-ray Source
News Mar 22, 2010
Excillum and Bruker AXS have announced an exclusive collaboration to develop and market a new metal-jet X-ray source for X-ray diffraction applications.
Bruker says that this new source is the fruit of many years of research at the Royal Institute of Technology in Stockholm, Sweden. It is more than ten times brighter than the laboratory sources available. This unequalled brightness can greatly benefit any experiment that currently employs a rotating anode generator (RAG) source, the company claims.
The new source also features a cost of ownership which is competitive with conventional RAG technology. Applications of interest include protein structure determination via X-ray crystallography, small angle X-ray scattering (SAXS and GI-SAXS) and all experiments where ultra-high X-ray flux on a small spot is essential.
Dr. Oscar Hemberg, CEO of Excillum, noted: "We are excited to work with Bruker AXS, a world leader in X-ray diffraction, to bring this new technology to the market. We believe the unprecedented brightness of this new source will allow researchers to bring many experiments, which previously could only be accomplished at a synchrotron beamline, into the home laboratory."
"We are looking forward to combining Excillum's cutting-edge source technology with Bruker AXS' comprehensive and best-in-class new product platform for X-ray diffraction," said Dr. Frank Burgaezy, Co-President of Bruker AXS. "This winning combination will open the doors to new laboratory applications for many researchers around the globe."
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE
Sciformix Corporation Collaborates with Oracle Health SciencesNews
New collaboration enables faster and more informed drug safety decisions.READ MORE
Quotient Sciences Launches as the New Global Identity for Quotient ClinicalNews
Quotient is focused on delivering a portfolio of innovative services encompassing formulation development, clinical trial and commercial manufacturing, and clinical pharmacology.READ MORE